SCHEMBL7335017

SCHEMBL7335017

CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NS(=O)(=O)N1CCCN(C)CC1)C(N)=O

nearest known ligand 0.52

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ REN P00797 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7330676 0.96 LTA4H (0.43) —
SCHEMBL7338182 0.86 REN (0.51) REN
SCHEMBL7335155 0.86 REN (0.46) REN
SCHEMBL7340387 0.86 REN (0.53) REN
SCHEMBL7333546 0.85 LTA4H (0.46) REN
SCHEMBL7339453 0.84 KMT2A (0.42) —
SCHEMBL7336138 0.82 REN (0.51) REN
SCHEMBL7338166 0.81 LTA4H (0.49) REN
SCHEMBL7338208 0.81 — —
SCHEMBL9437457 0.79 LTA4H (0.49) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5332742-A Ocular hypotensive ABBOTT LABORATORIES (US) 1994-07-26 — — US disclosed
US-5310740-A Congestive heart failure, hypotensive agents, antiglaucoma agents; side effect reduction ABBOTT LABORATORIES (US) 1994-05-10 — — US disclosed
US-5284849-A Treating hypertension and congestive heart failure ABBOTT LABORATORIES (US) 1994-02-08 — — US disclosed
EP-0456185-A2 Renin inhibitors ABBOTT LABORATORIES (US) 1991-11-13 — — EP disclosed
Send feedback